Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
Merck & Co Inc (NYSE: MRK) and Pfizer Inc (NYSE: PFE) have reportedly signaled that they have not agreed to a request by the Chinese authorities for deeper price cuts for COVID-19...
By Sam Boughedda Pfizer (NYSE:PFE) management presented at an investor conference yesterday and Chief Executive Albert Bourla is said to have reiterated plans for shaping...
By Sam Boughedda Morgan Stanley analysts labeled Moderna (NASDAQ:MRNA) a Catalyst Driven Idea in a note Friday, maintaining an Equal-Weight rating and $209 price target on the...
FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show Authored by Zachary Stieber via The Epoch Times (emphasis ours), U.S. drug regulators acknowledged...
This Censorious Pfizer Board Member Was A Major Influence On Lockdowns Authored by Jeffrey A. Tucker via the Brownstone Institute (emphasis ours), The latest of the Twitter Files...
Investors are looking for lucrative value plays and avoiding growth stocks amid rising interest rates and growing macro pressures. The ongoing turmoil has dragged down stocks of...
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.
| Average | 54.20 (+14.23% Upside) |
| High | 75.00 |
| Low | 44.00 |
| Price | 47.45 |
| No. of Analysts | 24 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Sell |
| Summary | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,422.00 | 1,429.00 | 1,401.00 | +2.00 | +0.14% | 110.44K | Philippines | |||
| 15.02 | 15.16 | 14.94 | 0.00 | 0.00% | 1.53M | Philippines | |||
| 241.80 | 243.00 | 239.60 | +0.20 | +0.08% | 255.74K | Philippines | |||
| 2.13 | 2.18 | 2.09 | +0.0200 | +0.95% | 6.61M | Philippines | |||
| 12.02 | 12.06 | 11.68 | +0.220 | +1.86% | 8.33M | Philippines | |||
| 2,064.00 | 2,096.00 | 2,054.00 | +4.00 | +0.19% | 23.39K | Philippines | |||
| 3.95 | 3.95 | 3.91 | 0.00 | 0.00% | 142.00K | Philippines | |||
| 1.31 | 1.33 | 1.28 | +0.03 | +2.34% | 580.00K | Philippines | |||
| 3.32 | 3.38 | 3.26 | -0.0600 | -1.78% | 2.78M | Philippines | |||
| 200.00 | 201.20 | 198.40 | 0.00 | 0.00% | 746.42K | Philippines | |||
| 0.90 | 0.91 | 0.89 | +0.020 | +2.27% | 518.00K | Philippines | |||
| 3.30 | 3.30 | 3.27 | -0.150 | -4.35% | 66.00K | Philippines | |||
| 18.24 | 18.56 | 18.00 | +0.04 | +0.22% | 7.18M | Philippines | |||
| 0.182 | 0.182 | 0.176 | 0.00 | 0.00% | 0.00 | Philippines | |||
| 35.60 | 36.50 | 35.50 | +0.10 | +0.28% | 164.70K | Philippines |